RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma

      한글로보기

      https://www.riss.kr/link?id=A104731981

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: Obesity is associated with aggressive pathological features and poor clinical outcomes in breast and prostate cancers. In papillary thyroid carcinoma (PTC), these relationships remain still controversial. This study aimed to evaluate the a...

      Background: Obesity is associated with aggressive pathological features and poor clinical outcomes in breast and prostate cancers. In papillary thyroid carcinoma (PTC), these relationships remain still controversial. This study aimed to evaluate the associations between body mass index (BMI) and the clinical outcomes of patients with PTC.
      Methods: This retrospective study included 1,189 patients who underwent total thyroidectomy for PTCs equal to or larger than 1 cm in size. Clinical outcomes were evaluated and compared based on the BMI quartiles.
      Results: There were no significant associations between BMI quartiles and primary tumor size, extrathyroidal invasion, cervical lymph node metastasis, or distant metastasis. However, an increase in mean age was associated with an increased BMI (P for trend <0.001). Multifocality and advanced tumor-node-metastasis (TNM) stage (stage III or IV) were significantly associated with increases of BMI (P for trend 0.02 and <0.001, respectively). However, these associations of multifocality and advanced TNM stage with BMI were not significant in multivariate analyses adjusted for age and gender. Moreover, there were no differences in recurrence-free survivals according to BMI quartiles (P=0.26).
      Conclusion: In the present study, BMI was not associated with the aggressive clinicopathological features or recurrence-free survivals in patients with PTC.

      더보기

      참고문헌 (Reference)

      1 대한내분비학회, "비만치료지침 2010 권고안" 대한내분비학회 25 (25): 301-304, 2010

      2 Borugian MJ, "Waist-to-hip ratio and breast cancer mortality" 158 : 963-968, 2003

      3 Paes JE, "The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study" 95 : 4244-4250, 2010

      4 Yim JH, "The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation" 96 : 2049-2056, 2011

      5 Ju-Yeon Kim, "The indices of body size and aggressiveness of papillary thyroid carcinoma" 대한외과학회 80 (80): 241-244, 2011

      6 Tresallet C, "The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices" 156 : 1145-1152, 2014

      7 Harari A, "Risk of advanced papillary thyroid cancer in obese patients" 147 : 805-811, 2012

      8 Hay ID, "Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period" 144 : 980-987, 2008

      9 Zhao ZG, "Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies" 40 : 2041-2050, 2012

      10 Appetecchia M, "Outcome after treatment of papillary thyroid microcarcinoma" 21 : 159-164, 2002

      1 대한내분비학회, "비만치료지침 2010 권고안" 대한내분비학회 25 (25): 301-304, 2010

      2 Borugian MJ, "Waist-to-hip ratio and breast cancer mortality" 158 : 963-968, 2003

      3 Paes JE, "The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study" 95 : 4244-4250, 2010

      4 Yim JH, "The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation" 96 : 2049-2056, 2011

      5 Ju-Yeon Kim, "The indices of body size and aggressiveness of papillary thyroid carcinoma" 대한외과학회 80 (80): 241-244, 2011

      6 Tresallet C, "The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices" 156 : 1145-1152, 2014

      7 Harari A, "Risk of advanced papillary thyroid cancer in obese patients" 147 : 805-811, 2012

      8 Hay ID, "Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period" 144 : 980-987, 2008

      9 Zhao ZG, "Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies" 40 : 2041-2050, 2012

      10 Appetecchia M, "Outcome after treatment of papillary thyroid microcarcinoma" 21 : 159-164, 2002

      11 World Health Organization, "Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity" World Health Organization 1997

      12 Strom SS, "Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy" 11 (11): 6889-6894, 2005

      13 Han JM, "Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population" 168 : 879-886, 2013

      14 De Pergola G, "Obesity as a major risk factor for cancer" 2013 : 291546-, 2013

      15 Marcello MA, "Obesity and thyroid cancer" 21 : T255-T271, 2014

      16 Xu L, "Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies" 24 : 966-974, 2014

      17 Marcello MA, "Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer" 64 : 1190-1195, 2012

      18 Wolin KY, "Obesity and cancer" 15 : 556-565, 2010

      19 Baudin E, "Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience" 83 : 553-559, 1998

      20 Protani M, "Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis" 123 : 627-635, 2010

      21 Collaborative Group on Hormonal Factors in Breast Cancer, "Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer" 350 : 1047-1059, 1997

      22 Renehan AG, "Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies" 371 : 569-578, 2008

      23 Rinaldi S, "Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study" 131 : E1004-E1014, 2012

      24 Kim HJ, "Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer" 78 : 134-140, 2013

      25 Edge S, "AJCC cancer staging manual" Springer 87-96, 2010

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-12-16 학술지명변경 한글명 : 대한내분비학회지 -> Endocrinology and Metabolism
      외국어명 : Endocrinology and Metabolism -> 미등록
      KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-06-28 학술지명변경 외국어명 : Journal of Korean Endocrin Society -> Endocrinology and Metabolism KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-06-05 학회명변경 영문명 : The Korean Society Of Endocrinology -> Korean Endocrin Society KCI등재
      2007-06-01 학술지명변경 외국어명 : Journal of Korean Society of Endocrinology -> Journal of Korean Endocrin Society KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.23 0.23 0.26
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.22 0.508 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼